Department of Pharmacy, University Medical Centre, Johannes Gutenberg-University Mainz, Mainz, Germany.
Eur J Hosp Pharm. 2020 Jul;27(4):209-215. doi: 10.1136/ejhpharm-2018-001745. Epub 2018 Nov 26.
The implementation of dose-banding (DB) in centralised, pharmacy-based cytotoxic drug preparation units allows the preparation of standardised doses in series. The aim of this study was to evaluate the feasibility of DB for the prescribing of ganciclovir (GV) infusion solutions and to investigate the microbiological stability of dose-banded, automatically prepared ready-to-administer GV infusion bags by media-fill simulation tests and sterility tests.
The frequency of prescription of GV doses was retrospectively analysed before and after implementing the DB scheme. Four dose-ranges or 'bands' and the corresponding standard doses (250, 300, 350, 400 mg) were identified. The maximum variance was set at ±10% of the individually prescribed dose. The aseptic preparation of a series of GV infusion bags was simulated with double strength tryptic soy broth as growth medium and prefilled 0.9% NaCl polyolefin infusion bags as primary packaging materials. The simulation process was performed with the APOTECAchemo robot on five consecutive days. In total, 50 infusion bags were filled, incubated and stored for 12 weeks at room temperature. The media-filled bags were visually inspected for turbidity after 2, 4, 8, 10 and 12 weeks. Following incubation, growth promotion tests were performed. During the simulation tests, airborne contamination was monitored with settle plates and microbial surface contamination with contact plates. Pooled sterility tests were performed for a series of 10 standard GV infusion bags after a 12-week storage period under refrigeration (2 °C-8 °C).
After implementation of the DB scheme, about 60% of the prescribed GV doses were prepared as standard preparations by the robotic system. The number of different GV doses was reduced by 61.8% (76 vs 29). None of the 50 media-filled bags showed turbidity after a storage period of 12 weeks, indicating the absence of microorganisms. The environmental monitoring with settle/contact plates matched the recommended limits set for cleanroom Grade A zones, except in the loading area of the robot. Media fills used for the sterility tests remained clear during the incubation period, thereby revealing sterility. Positive growth promotion tests proved the process's reliability.
A DB scheme for prescribing and preparation of standard GV infusion bags was successfully implemented. Microbiological tests of aseptic preparation of infusion bags in series by the APOTECAchemo robot revealed an adequate level of sterility and a well-controlled aseptic procedure. The sterility was maintained over extended storage periods, thereby encouraging extended beyond-use dating.
在集中式、基于药房的细胞毒性药物制备单元中实施剂量分段(DB)允许制备一系列标准化剂量。本研究的目的是评估 DB 用于制定更昔洛韦(GV)输注溶液的处方的可行性,并通过培养基填充模拟试验和无菌试验研究自动制备的即用型剂量分段、制备的更昔洛韦输注袋的微生物稳定性。
回顾性分析实施 DB 方案前后 GV 剂量的处方频率。确定了四个剂量范围或“波段”和相应的标准剂量(250、300、350、400mg)。最大方差设定为个体规定剂量的±10%。使用双份浓度的胰蛋白酶大豆肉汤作为生长培养基和预填充 0.9%氯化钠聚烯烃输注袋作为初级包装材料,用 APOTECAchemo 机器人模拟一系列 GV 输注袋的无菌制备。模拟过程在连续五天内进行。总共填充了 50 个输液袋,在室温下孵育并储存 12 周。在第 2、4、8、10 和 12 周后,对填充培养基的袋子进行浊度检查。孵育后,进行生长促进试验。在模拟试验过程中,沉降平板监测空气传播污染,接触平板监测微生物表面污染。在冷藏(2°C-8°C)下储存 12 周后,对一系列 10 个标准 GV 输注袋进行了汇总无菌试验。
实施 DB 方案后,约 60%的规定 GV 剂量由机器人系统制备为标准制剂。不同 GV 剂量的数量减少了 61.8%(76 对 29)。在 12 周的储存期后,没有一个填充培养基的袋子显示出浑浊,表明没有微生物。沉降/接触平板的环境监测符合推荐的 A 级洁净室区域限值,除了机器人的装载区。用于无菌试验的培养基填充在孵育期间保持清晰,从而证明了无菌性。阳性生长促进试验证明了该过程的可靠性。
成功实施了更昔洛韦输注袋的处方和制备的 DB 方案。APOTECAchemo 机器人系列无菌制备输注袋的微生物学试验显示出足够的无菌水平和良好控制的无菌程序。在延长的储存期内保持无菌性,从而鼓励延长使用期限。